scispace - formally typeset
K

Karin Aase

Researcher at Ludwig Institute for Cancer Research

Publications -  17
Citations -  2180

Karin Aase is an academic researcher from Ludwig Institute for Cancer Research. The author has contributed to research in topics: Vascular endothelial growth factor B & Receptor. The author has an hindex of 11, co-authored 17 publications receiving 2127 citations.

Papers
More filters
Journal ArticleDOI

PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.

TL;DR: A new PDGF, PDGF-C, is identified, which binds to and activates the PDGF α-receptor and is activated by proteolysis and induces proliferation of fibroblasts when overexpressed in transgenic mice.
Journal ArticleDOI

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells.

TL;DR: The binding of VEGF-B to its receptor on endothelial cells leads to increased expression and activity of urokinase type plasminogen activator and plasmineg activator inhibitor 1, suggesting a role for VEGf-B in the regulation of extracellular matrix degradation, cell adhesion, and migration.
Journal ArticleDOI

Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors

TL;DR: The expression of VEGF-C is associated with the development of lymphatic vessels, and VEGf-C could be an important factor regulating the mutual paracrine relationships between tumor cells and lymphatic endothelial cells.
Journal ArticleDOI

Vascular Endothelial Growth Factor-B–Deficient Mice Display an Atrial Conduction Defect

TL;DR: VEGF-B seems to be required for normal heart function in adult animals but is not required for proper development of the cardiovascular system either during development or for angiogenesis in adults.
Journal ArticleDOI

Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy.

TL;DR: A transgenic mouse that exhibits cardiac fibrosis followed by hypertrophy with sex-dependent phenotypes is created and reveals that a potent mitogen for cardiac fibroblasts result in an expansion of the interstitium that induce a secondary sex- dependent hypertrophic response in the cardiomyocytes.